Yeji
PDUFAconf 0.99

axs-07 — PDUFA

$AXSM · Axsome Therapeutics, Inc. · acute treatment of migraine
Event date
January 31, 2025
491 days ago
Sponsor runway
44 mo
$305.1M liquid

Evidence

The FDA designated the resubmission as a Class 2 resubmission and set a Prescription Drug User Fee Act (PDUFA) action goal date of January 31, 2025.
Source: Press release · 2024-09-04View press release ↗

Comparable historical pdufas· last 5 years · same indication

0% hit rate (0/1)
TickerDrugDateOutcome
$AXSMaxs-072022-04-30failure

Recent insider activity· ±90 days

9 insiders · 0 buys · 2 sells
Grant
2025-02-24
Murdock Hunter R.
General Counsel
7,740 @
Grant
2025-02-24
Pizzie Nick
Chief Financial Officer
9,423 @
Grant
2025-02-24
TABUTEAU HERRIOT
Chief Executive Officer
28,609 @
Grant
2025-02-24
Jacobson Mark L.
Chief Operating Officer
10,769 @
Grant
2025-02-24
Maizel Ari
Chief Commercial Officer
7,740 @
Grant
2025-02-21
Jacobson Mark L.
Chief Operating Officer
10,875 @
Grant
2025-02-21
Jacobson Mark L.
Chief Operating Officer
10,769 @
Grant
2025-02-21
Murdock Hunter R.
General Counsel
7,816 @
Grant
2025-02-21
Murdock Hunter R.
General Counsel
7,740 @
Grant
2025-02-21
JEFFS ROGER
Director
1,408 @
Grant
2025-02-21
Pizzie Nick
Chief Financial Officer
9,516 @
Grant
2025-02-21
Pizzie Nick
Chief Financial Officer
9,423 @
Grant
2025-02-21
Saad Mark E
Director
1,494 @
Grant
2025-02-21
Maizel Ari
Chief Commercial Officer
7,816 @
Grant
2025-02-21
Maizel Ari
Chief Commercial Officer
7,740 @
Grant
2025-02-21
TABUTEAU HERRIOT
Chief Executive Officer
28,887 @
Grant
2025-02-21
TABUTEAU HERRIOT
Chief Executive Officer
28,609 @
Grant
2025-02-21
Mahony Susan
Director
1,312 @
Exercise10b5-1
2025-02-14
Pizzie Nick
Chief Financial Officer
3,000 @ $3.50$11K
Sell10b5-1
2025-02-14
Pizzie Nick
Chief Financial Officer
3,000 @ $131.07$393K
Exercise10b5-1
2025-02-13
Pizzie Nick
Chief Financial Officer
12,000 @ $3.50$42K
Sell10b5-1
2025-02-13
Pizzie Nick
Chief Financial Officer
12,000 @ $129.86$1.56M
Exercise
2025-01-03
Coleman Mark
Director
9,127 @ $9.00$82K
Exercise
2024-11-19
Coleman Mark
Director
33,410 @ $5.94$198K